Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2025 | Story André Damons | Photo Supplied
Prof Wynand Goosen
Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards.

Being nominated for a ‘Science Oscar’ is exciting and validates nominees’ efforts, particularly in a field as challenging and essential as infectious diseases, for which they are recognised at the highest level. 

This is according to Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State (UFS). He was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards for his landmark discovery of Mycobacterium bovis infection in humans in South Africa – the first confirmed cases in the country. 

Prof Goosen, who previously won the NSTF-South32 Emerging Researcher Award, says the nomination is a powerful affirmation of the impact that focused, interdisciplinary research can have. It reflects not only his personal commitment but also the dedication of a talented and hard-working team. “I am honoured and humbled to be nominated. It is also a testament to the support and vision of UFS, particularly as we position ourselves as leaders in One Health research in South Africa,” he says. 

 

Focus of research 

He was nominated by Prof Vasu Reddy, UFS Deputy Vice-Chancellor: Research and Internationalisation, and Prof Paul Oberholster, Dean for the Faculty of Natural and Agricultural Sciences (NAS) at the UFS, and Prof Nico Gey van Pittius and Prof Elmi Muller from Stellenbosch University (US). The NSTF Awards, known as the ‘Science Oscars’of SA, honour, reward, celebrate, profile and promote outstanding contributions to science, engineering and technology (SET) and innovation in South Africa.

“The nomination,” Prof Goosen continues, “recognises our work in the field of zoonotic tuberculosis (TB) and other emerging infectious diseases at the human-animal-environment interface. Our research focuses on the molecular detection and characterisation of pathogenic mycobacteria in wildlife, livestock, and human populations, with the aim of informing better surveillance, diagnostics, and control strategies — particularly in high-risk ecosystems. This includes novel applications in wildlife TB surveillance and understanding the transmission dynamics between animals and people.”

 

Establishing a Kovsie One Health Research Unit

This research is critically important as South Africa continues to face a high burden of tuberculosis, including zoonotic TB, which often goes under-detected in rural and wildlife-rich areas. Understanding how these pathogens circulate between humans, animals, and the environment, explains Prof Goosen, is essential for effective disease control and to mitigate future pandemics. This work directly supports national health priorities, informs policy, and contributes to global strategies for One Health.

Prof Goosen and the team are in the process of laying the groundwork for the establishment of a Kovsie One Health Research Unit, which will serve as a collaborative platform for research spanning human, animal, and environmental health. One of their key projects involves expanding TB and AMR surveillance in wildlife-livestock-human interfaces, using cutting-edge diagnostics and genomic tools. They are also initiating partnerships with industry and international institutions to address emerging zoonoses and environmental pathogens in a transdisciplinary manner.

News Archive

UFS becomes partner of national bursary competition for the performing arts
2008-11-28

The Department of Drama and Theatre Arts at the University of the Free State (UFS) has become a partner of the Arts & Culture Trust (ACT) and the Dramatic, Artistic, and Literary Rights Organisation’s (DALRO) new bursary programme for the performing arts.

The ACT DALRO Scholarship Programme will be implemented for the first time in 2009. For the following three years (2009-2011) one learner will receive
R75 000 per year that will be used to pay for his/her studies to an accredited undergraduate tertiary institution of their choice in the performing arts.

Grade 12 learners are invited to participate in the national competition where their abilities to act, sing and dance will be judged. Individuals who already matriculated and who are not registered for a formal course in the performing arts, are also encouraged to participate. Schools, drama clubs and colleges may also register a group of learners.

An elimination round of the competition will take place next year on 21 and 22 July 2009 at the Scaena Theatre on the UFS Main Campus in Bloemfontein.

The registration fee is R200 per participant and a limited number of registrations will be subsidised. The closing date for the applications for subsidies is 31 March 2009 and registration of individuals and/or organisations is 30 April 2009.

Register at the Department of Drama and Theatre Arts at the UFS or fax the necessary documents to 051 401 3494. Application forms, rules and requirements to prepare for the competition can be requested from kamperm.hum@ufs.ac.za or fax a request to 051 401 3493.

Finalists must be available for the final round that will take place in September 2009 in Johannesburg. ACT will carry the cost of the transport and accommodation of the finalists for the final round.

Ms Marijda Kamper can be contacted at 051 401 2160 or kamperm.hum@ufs.ac.za  for more information regarding the Free State round. Mr Pieter Jacobs can be contacted at 011 802 7646 or pieter@act.org.za for general enquiries about the ACT Programme, or visit www.act.org.za .


Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
28 November 2008
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept